Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 27;8(1):52-64.
doi: 10.4240/wjgs.v8.i1.52.

Esophageal surgery in minimally invasive era

Affiliations
Review

Esophageal surgery in minimally invasive era

Lapo Bencini et al. World J Gastrointest Surg. .

Abstract

The widespread popularity of new surgical technologies such as laparoscopy, thoracoscopy and robotics has led many surgeons to treat esophageal diseases with these methods. The expected benefits of minimally invasive surgery (MIS) mainly include reductions of postoperative complications, length of hospital stay, and pain and better cosmetic results. All of these benefits could potentially be of great interest when dealing with the esophagus due to the potentially severe complications that can occur after conventional surgery. Moreover, robotic platforms are expected to reduce many of the difficulties encountered during advanced laparoscopic and thoracoscopic procedures such as anastomotic reconstructions, accurate lymphadenectomies, and vascular sutures. Almost all esophageal diseases are approachable in a minimally invasive way, including diverticula, gastro-esophageal reflux disease, achalasia, perforations and cancer. Nevertheless, while the limits of MIS for benign esophageal diseases are mainly technical issues and costs, oncologic outcomes remain the cornerstone of any procedure to cure malignancies, for which the long-term results are critical. Furthermore, many of the minimally invasive esophageal operations should be compared to pharmacologic interventions and advanced pure endoscopic procedures; such a comparison requires a difficult literature analysis and leads to some confounding results of clinical trials. This review aims to examine the evidence for the use of MIS in both malignancies and more common benign disease of the esophagus, with a particular emphasis on future developments and ongoing areas of research.

Keywords: Esophageal cancer; Esophageal disease; Esophageal diverticula; Heller; Laparoscopic; Reflux disease; Robotic; da Vinci.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Incidence and mortality rates of esophageal cancer worldwide[114].
Figure 2
Figure 2
da Vinci® docking during the thoracic step of a completely robotic esophagectomy at the Division of Oncologic Surgery and Robotics, Careggi Hospital.

Similar articles

Cited by

References

    1. McCulloch P, Ward J, Tekkis PP. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ. 2003;327:1192–1197. - PMC - PubMed
    1. Gopaldas RR, Bhamidipati CM, Dao TK, Markley JG. Impact of surgeon demographics and technique on outcomes after esophageal resections: a nationwide study. Ann Thorac Surg. 2013;95:1064–1069. - PubMed
    1. Low DE, Bodnar A. Update on clinical impact, documentation, and management of complications associated with esophagectomy. Thorac Surg Clin. 2013;23:535–550. - PubMed
    1. Markar SR, Karthikesalingam A, Thrumurthy S, Low DE. Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000-2011. J Gastrointest Surg. 2012;16:1055–1063. - PubMed
    1. Goldfarb M, Brower S, Schwaitzberg SD. Minimally invasive surgery and cancer: controversies part 1. Surg Endosc. 2010;24:304–334. - PMC - PubMed

LinkOut - more resources